Erratum: Clinical responses to ERK inhibition in BRAFV600E-mutant colorectal cancer predicted using a computational model

被引：0
|
作者：
Daniel C. Kirouac
Gabriele Schaefer
Jocelyn Chan
Mark Merchant
Christine Orr
Shih-Min A. Huang
John Moffat
Lichuan Liu
Kapil Gadkar
Saroja Ramanujan
机构：
[1] Genentech Research & Early Development,
来源：
npj Systems Biology and Applications | / 3卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
A correction to this article has been published and is linked from the HTML version of this article.
引用
收藏
相关论文
共 50 条
  • [1] Clinical responses to ERK inhibition in BRAFV600E-mutant colorectal cancer predicted using a computational model
    Daniel C. Kirouac
    Gabriele Schaefer
    Jocelyn Chan
    Mark Merchant
    Christine Orr
    Shih-Min A. Huang
    John Moffat
    Lichuan Liu
    Kapil Gadkar
    Saroja Ramanujan
    [J]. npj Systems Biology and Applications, 3
  • [2] Clinical responses to ERK inhibition in BRAFV600E-mutant colorectal cancer predicted using a computational model
    Kirouac, Daniel C.
    Schaefer, Gabriele
    Chan, Jocelyn
    Merchant, Mark
    Orr, Christine
    Huang, Shih-Min A.
    Moffat, John
    Liu, Lichuan
    Gadkar, Kapil
    Ramanujan, Saroja
    [J]. NPJ SYSTEMS BIOLOGY AND APPLICATIONS, 2017, 3
  • [3] Clinical responses to ERK inhibition in BRAFV600E-mutant Colorectal Cancer Predicted Using a QSP-based Computational Model
    Kirouac, Daniel C.
    Schaeffer, Gabriele
    Chan, Jocelyn
    Merchant, Mark
    Orr, Christine
    Liu, Lichuan
    Huang, Alex
    Moffat, John
    Gadkar, Kapil
    Ramanujan, Saroja
    [J]. JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS, 2017, 44 : S23 - S23
  • [4] Clinical responses to ERK inhibition in BRAFV600E-mutant colorectal cancer predicted using a computational model (vol 3, 14, 2017)
    Kirouac, Daniel C.
    Schaefer, Gabriele
    Chan, Jocelyn
    Merchant, Mark
    Orr, Christine
    Huang, Shih-Min A.
    Moffat, John
    Liu, Lichuan
    Gadkar, Kapil
    Ramanujan, Saroja
    [J]. NPJ SYSTEMS BIOLOGY AND APPLICATIONS, 2017, 3
  • [5] Improvements in Clinical Outcomes for BRAFV600E-Mutant Metastatic Colorectal Cancer
    Morris, Van K.
    Bekaii-Saab, Tanios
    [J]. CLINICAL CANCER RESEARCH, 2020, 26 (17) : 4435 - 4441
  • [6] COMBINED BRAFV600E AND MEK INHIBITION FOR BRAFV600E-MUTANT ASTROCYTOMAS
    Zhang, Jie
    Hariono, Sujatmi
    Yao, Tsun-Wen
    Sidhu, Angadpreet
    Hashizume, Rintaro
    James, C. David
    Weiss, William A.
    Nicolaides, Theodore P.
    [J]. NEURO-ONCOLOGY, 2013, 15 : 60 - 61
  • [7] European expert panel consensus on the clinical management of BRAFV600E-mutant metastatic colorectal cancer
    Martinelli, Erika
    Arnold, Dirk
    Cervantes, Andres
    Stintzing, Sebastian
    Van Cutsem, Eric
    Tabernero, Josep
    Taieb, Julien
    Wasan, Harpreet
    Ciardiello, Fortunato
    [J]. CANCER TREATMENT REVIEWS, 2023, 115
  • [8] Dual Wnt and EGFR-MAPK dependency of BRAFV600E-mutant colorectal cancer
    Wang, Youzhen
    Palmer, Michael
    Jaeger, Savina
    Bagdasarian, Linda
    Qiu, Shumei
    Woolfenden, Steve
    Meyer, Ronald
    Yang, Guizhi
    Green, John
    Pan, Shifeng
    Liu, Jun
    Gao, Hui
    Cao, Z. Alexander
    Myers, Andrea
    McLaughlin, Margaret E.
    [J]. CANCER RESEARCH, 2015, 75
  • [9] A comprehensive overview of the molecular features and therapeutic targets in BRAFV600E-mutant colorectal cancer
    Gu, Ruiqi
    Fang, Hongsheng
    Wang, Renjie
    Dai, Weixing
    Cai, Guoxiang
    [J]. CLINICAL AND TRANSLATIONAL MEDICINE, 2024, 14 (07):
  • [10] Chemotherapy-free Treatment of Patients with BRAFV600E-mutant metastatic Colorectal Cancer
    不详
    [J]. ONCOLOGY RESEARCH AND TREATMENT, 2020, 43 (06)
12345